Study Evaluating TMI-005 in Active Rheumatoid Arthritis

Summary

The primary objective of this clinical research study is to compare the efficacy and the safety of 3 dose levels of oral TMI-005 in comparison with placebo in subjects with active Rheumatoid Arthritis (RA) who have been receiving stable doses of Methotrexate (MTX).

Timeline

Start

—

Primary completion

2005-08

Completion

2005-08

Drugs

Indications